» Articles » PMID: 21794181

Pre-ejection Period by Radial Artery Tonometry Supplements Echo Doppler Findings During Biventricular Pacemaker Optimization

Overview
Publisher Biomed Central
Date 2011 Jul 29
PMID 21794181
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Biventricular (Biv) pacemaker echo optimization has been shown to improve cardiac output however is not routinely used due to its complexity. We investigated the role of a simple method involving computerized pre-ejection time (PEP) assessment by radial artery tonometry in guiding Biv pacemaker optimization.

Methods: Blinded echo and radial artery tonometry were performed simultaneously in 37 patients, age 69.1 ± 12.8 years, left ventricular (LV) ejection fraction (EF) 33 ± 10%, during Biv pacemaker optimization. Effect of optimization on echo derived velocity time integral (VTI), ejection time (ET), myocardial performance index (MPI), radial artery tonometry derived PEP and echo-radial artery tonometry derived PEP/VTI and PEP/ET indices was evaluated.

Results: Significant improvement post optimization was achieved in LV ET (286.9 ± 37.3 to 299 ± 34.6 ms, p < 0.001), LV VTI (15.9 ± 4.8 cm to 18.4 ± 5.1 cm, p < 0.001) and MPI (0.57 ± 0.2 to 0.45 ± 0.13, p < 0.001) and in PEP (246.7 ± 36.1 ms to 234.7 ± 35.5 ms, p = 0.003), PEP/ET (0.88 ± 0.21 to 0.79 ± 0.17, p < 0.001), and PEP/VTI (17.3 ± 7 to 13.78 ± 4.7, p < 0.001). The correlation between comprehensive echo Doppler and radial artery tonometry-PEP guided optimal atrioventricular delay (AVD) and optimal interventricular delay (VVD) was 0.75 (p < 0.001) and 0.69 (p < 0.001) respectively. In 29 patients with follow up assessment, New York Heart Association (NYHA) class reduced from 2.5 ± 0.8 to 2.0 ± 0.9 (p = 0.004) at 1.8 ± 1.4 months.

Conclusion: An acute shortening of PEP by radial artery tonometry occurs post Biv pacemaker optimization and correlates with improvement in hemodynamics by echo Doppler and may provide a cost-efficient approach to assist with Biv pacemaker echo optimization.

Citing Articles

Pulse arrival time variation as a non-invasive marker of acute response to cardiac resynchronization therapy.

Villegas-Martinez M, Odland H, Hammersboen L, Sletten O, Stugaard M, Witso M Europace. 2023; 25(3):1183-1192.

PMID: 36734281 PMC: 10062362. DOI: 10.1093/europace/euad013.


Systolic time intervals derived from electrocardiographic gated intra-renal artery Doppler waveform associated with left ventricular systolic function.

Lee W, Hsu P, Chu C, Chen S, Lee H, Lee M Sci Rep. 2016; 6:29293.

PMID: 27553182 PMC: 4995511. DOI: 10.1038/srep29293.


Shortening of atrioventricular delay at increased atrial paced heart rates improves diastolic filling and functional class in patients with biventricular pacing.

Rafie R, Qamruddin S, Ozhand A, Taha N, Naqvi T Cardiovasc Ultrasound. 2012; 10:2.

PMID: 22269022 PMC: 3292936. DOI: 10.1186/1476-7120-10-2.

References
1.
Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, FEIGENBAUM H . Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2(5):358-67. DOI: 10.1016/s0894-7317(89)80014-8. View

2.
Tei C, Ling L, Hodge D, Bailey K, Oh J, Rodeheffer R . New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol. 1995; 26(6):357-66. View

3.
Stanton T, Hawkins N, Hogg K, Goodfield N, Petrie M, McMurray J . How should we optimize cardiac resynchronization therapy?. Eur Heart J. 2008; 29(20):2458-72. DOI: 10.1093/eurheartj/ehn380. View

4.
Lavine S . Effect of heart rate and preload on index of myocardial performance in the normal and abnormal left ventricle. J Am Soc Echocardiogr. 2005; 18(2):133-41. DOI: 10.1016/j.echo.2004.08.036. View

5.
Baker C, Love C, Moeschberger M, Orsinelli D, Yamokoski L, Leier C . Time intervals of cardiac resynchronization therapy in heart failure. Am J Cardiol. 2004; 94(9):1192-6. DOI: 10.1016/j.amjcard.2004.07.094. View